Aktuellt
SENASTE
Bactiguard’s Q2 sales of SEK 57m were 18% better than SEB with organic net sales growth of 30% y/y (SEBe: 10% y/y) in the quarter. License revenues are behind the Q2 beat. Q2 EBITDA was SEK 1m (SEB at SEK -4m), with FCF coming in positive as well (SEK 9m). Cost of raw materials and opex items were only slightly higher versus SEB and we note that the company is delivering on its reshaped strategy set out during 2023. Bactiguard’s financial targets remain. A solid report.
LÄS MER
